Tirzepatide-induced gastrointestinal manifestations: A systematic review and meta-analysis, Cureus (2023) The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists, Diabetes, Obesity, and Metabolism (2020) What is the incidence of pancreatitis associated with Zepbound (tirzepatide)?, Eli Lilly website (2024) Constipation and impaction, Harvard Health (2023) Pancreatitis, Johns Hopkins Medicine (2025) Gallstones and gallbladder disease, Mount Sinai Zepbound label, Food and Drug Administration (2025) Gingers nutritional implication on gastrointestinal health, Clinical Nutrition Open Science (2025) Review article: The physiologic effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders, Alimentary Pharmacology and Therapeutics (2018) Efficacy and safety of peppermint oil in a randomized double-blind trial of patients with irritable bowel syndrome, Gastroenterology (2020) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

Label your vial clearly with the reconstitution date using a permanent marker to avoid confusion
I, Kerry Traugott, DNP, provide a personalized approach
Poor sleep is linked to weight gain as it can result in exhausted daysso you may avoid exercise and reach for carbs to give you quick energy, says Dr
Zepbound Safety Disclaimer: Zepbound carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Is Mounjaro Alcohol Interaction Not Safe